Clorox (NYSE:CLX) Price Target Cut to $100.00 by Analysts at Wells Fargo & Company

Clorox (NYSE:CLXGet Free Report) had its target price cut by equities research analysts at Wells Fargo & Company from $110.00 to $100.00 in a report issued on Friday,Benzinga reports. The firm presently has an “equal weight” rating on the stock. Wells Fargo & Company‘s target price indicates a potential upside of 12.91% from the company’s current price.

Other equities analysts have also issued research reports about the company. Royal Bank Of Canada lowered their price objective on Clorox from $132.00 to $127.00 and set a “sector perform” rating for the company in a research report on Thursday, April 9th. BNP Paribas Exane raised Clorox from an “underperform” rating to a “neutral” rating in a research report on Wednesday, February 11th. TD Cowen lifted their price target on Clorox from $98.00 to $111.00 and gave the stock a “hold” rating in a research report on Tuesday, March 31st. Jefferies Financial Group lowered their price target on Clorox from $151.00 to $139.00 and set a “buy” rating for the company in a research report on Tuesday, April 21st. Finally, Barclays set a $85.00 price target on Clorox in a research report on Friday. One analyst has rated the stock with a Buy rating, twelve have issued a Hold rating and four have assigned a Sell rating to the company’s stock. According to data from MarketBeat, Clorox presently has a consensus rating of “Reduce” and a consensus target price of $107.13.

Check Out Our Latest Analysis on CLX

Clorox Stock Down 8.2%

Clorox stock traded down $7.88 on Friday, hitting $88.57. 1,809,935 shares of the stock traded hands, compared to its average volume of 2,302,860. The company has a current ratio of 0.74, a quick ratio of 0.48 and a debt-to-equity ratio of 71.03. The firm has a market cap of $10.71 billion, a P/E ratio of 14.49, a price-to-earnings-growth ratio of 0.47 and a beta of 0.65. The business’s fifty day simple moving average is $108.21 and its 200 day simple moving average is $108.82. Clorox has a 1 year low of $86.79 and a 1 year high of $140.24.

Clorox (NYSE:CLXGet Free Report) last announced its quarterly earnings data on Thursday, April 30th. The company reported $1.64 EPS for the quarter, beating the consensus estimate of $1.55 by $0.09. The business had revenue of $1.67 billion during the quarter, compared to analyst estimates of $1.67 billion. Clorox had a return on equity of 383.01% and a net margin of 11.17%.The company’s revenue for the quarter was up .1% on a year-over-year basis. During the same quarter last year, the firm posted $1.45 earnings per share. Clorox has set its FY 2026 guidance at 5.450-5.650 EPS. As a group, sell-side analysts forecast that Clorox will post 5.87 earnings per share for the current year.

Hedge Funds Weigh In On Clorox

Hedge funds have recently bought and sold shares of the business. Haverford Trust Co raised its holdings in shares of Clorox by 2.8% during the fourth quarter. Haverford Trust Co now owns 3,070 shares of the company’s stock valued at $310,000 after purchasing an additional 84 shares during the period. Field & Main Bank grew its position in Clorox by 3.3% in the 4th quarter. Field & Main Bank now owns 3,100 shares of the company’s stock worth $313,000 after purchasing an additional 100 shares in the last quarter. Golden State Wealth Management LLC grew its position in Clorox by 28.2% in the 4th quarter. Golden State Wealth Management LLC now owns 454 shares of the company’s stock worth $46,000 after purchasing an additional 100 shares in the last quarter. Fisher Asset Management LLC grew its position in shares of Clorox by 1.7% during the 3rd quarter. Fisher Asset Management LLC now owns 6,053 shares of the company’s stock valued at $746,000 after acquiring an additional 102 shares during the period. Finally, Kestra Private Wealth Services LLC grew its position in shares of Clorox by 1.8% during the 1st quarter. Kestra Private Wealth Services LLC now owns 5,957 shares of the company’s stock valued at $617,000 after acquiring an additional 104 shares during the period. Hedge funds and other institutional investors own 78.53% of the company’s stock.

Key Headlines Impacting Clorox

Here are the key news stories impacting Clorox this week:

Clorox Company Profile

(Get Free Report)

The Clorox Company is a leading manufacturer and marketer of consumer and professional products designed to help people care for their homes and live healthy, sustainable lives. Its portfolio spans cleaning and household products, food and beverages, water filtration systems and cat litter, serving both retail and institutional customers. The company’s flagship bleach and disinfecting products are well known in the United States and many international markets, where they help prevent the spread of germs in homes, hospitals, schools and businesses.

Clorox’s diverse brand lineup includes liquid bleach and surface cleaners, eco-friendly cleaning tools, food preservation and preparation items, charcoal grills and briquettes, specialty foods and beverages, pet care products and personal care lines.

Featured Stories

Analyst Recommendations for Clorox (NYSE:CLX)

Receive News & Ratings for Clorox Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Clorox and related companies with MarketBeat.com's FREE daily email newsletter.